BCMU
ELV icon

BlueCrest Capital Management (UK)’s Elevance Health ELV Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-40,331
Closed -$4.01M – 614
2014
Q1 		$4.01M Buy
+40,331
New +$3.65M 0.23% 114

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

BlueCrest Capital Management (UK)'s ELV Position: Q2 2014 in Review

BlueCrest Capital Management (UK) sold out of Elevance Health (ELV) in Q2 2014, closing a stake of 40,331 shares — an estimated $4.01M sold.

BlueCrest Capital Management (UK) first reported a position in ELV in Q1 2014 and held it in 1 quarter. The position peaked at $4.01M in Q1 2014. 686 funds tracked by Wall St. Rank hold ELV as of Q2 2014.

  • BlueCrest Capital Management (UK) reported no remaining Elevance Health position as of Q2 2014 after selling out during the quarter.
  • BlueCrest Capital Management (UK) sold 40,331 Elevance Health shares in Q2 2014, an estimated $4.01M.
  • BlueCrest Capital Management (UK) first reported a position in Elevance Health in Q1 2014 and held it in 1 quarter.
  • BlueCrest Capital Management (UK)'s Elevance Health position peaked at $4.01M in Q1 2014.
  • 686 funds tracked by Wall St. Rank held Elevance Health as of Q2 2014.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q2 2014, filed 15 Aug 2014.